Tendonitis, Myositis and Bursitis DRG Reimbursement Guide

Clinical Trials

Acute procedural intervention trials investigating effectiveness and safety of minimally invasive tendon or bursa interventions (such as ultrasound-guided corticosteroid injections versus image-guided needle tenotomy) in hospitalized patients with severe tendonitis, myositis, or bursitis who have failed outpatient care; these studies enroll patients early in their inpatient course to measure short-term pain reduction, functional improvement, and avoidance of surgical escalation, and are relevant to providers and payers because demonstrated inpatient procedures that reduce length of stay or prevent higher-cost interventions can inform care pathways and resource allocation.
Comparative effectiveness trials of multimodal nonoperative management strategies for moderate-to-severe inflammatory soft-tissue disorders in medically complex inpatients, comparing combinations such as optimized physical therapy regimens, systemic anti-inflammatory strategies, and localized therapies; these studies focus on patients with comorbidities (eg, diabetes, obesity, anticoagulation) who may respond differently to conservative care and address which bundles of therapies improve function and reduce readmissions, providing evidence to guide inpatient protocols and reimbursement decisions.
Post-discharge outcomes and utilization studies examining long-term functional recovery, recurrence rates, outpatient rehabilitation needs, and healthcare utilization among patients discharged after inpatient treatment for tendonitis, myositis, or bursitis; these observational studies follow diverse populations (including older adults and those with work-related musculoskeletal issues) to identify predictors of readmission, durable functional outcomes, and cost drivers, which helps payers evaluate post-acute care benefits and providers design transitions of care that reduce downstream costs.

Single Level Combined Anterior and Posterior Spinal Fusion Except Cervical: Inpatient Reimbursement Overview

426-MULTIPLE-LEVEL-COMBINED-ANTERIOR-AND-POSTERIOR-SPINAL-FUSION-EXCEPT-CERVICAL-WITH-MCC-OR-CUSTOM-MADE-ANATOMICALLY-DESIGNED-INTERBODY-FUSION-DEVICE

Multiple Level Combined Anterior and Posterior Spinal Fusion Except Cervical with MCC or Custom-Made Anatomically Designed Interbody Fusion Device: Inpatient Reimbursement Overview

427-MULTIPLE-LEVEL-COMBINED-ANTERIOR-AND-POSTERIOR-SPINAL-FUSION-EXCEPT-CERVICAL-WITH-CC

Multiple Level Combined Anterior and Posterior Spinal Fusion Except Cervical with CC: Inpatient Reimbursement Overview

428-MULTIPLE-LEVEL-COMBINED-ANTERIOR-AND-POSTERIOR-SPINAL-FUSION-EXCEPT-CERVICAL-WITHOUT-CC-MCC

Multiple Level Combined Anterior and Posterior Spinal Fusion Except Cervical without CC/MCC: Inpatient Reimbursement Overview

429-COMBINED-ANTERIOR-AND-POSTERIOR-CERVICAL-SPINAL-FUSION-WITH-MCC

Combined Anterior and Posterior Cervical Spinal Fusion with MCC: Inpatient Reimbursement Overview

430-COMBINED-ANTERIOR-AND-POSTERIOR-CERVICAL-SPINAL-FUSION-WITHOUT-MCC

Combined Anterior and Posterior Cervical Spinal Fusion without MCC: Inpatient Reimbursement Overview

447-MULTIPLE-LEVEL-SPINAL-FUSION-EXCEPT-CERVICAL-WITH-MCC-OR-CUSTOM-MADE-ANATOMICALLY-DESIGNED-INTERBODY-FUSION-DEVICE

Multiple Level Spinal Fusion Except Cervical with MCC: Inpatient Reimbursement Overview

448-MULTIPLE-LEVEL-SPINAL-FUSION-EXCEPT-CERVICAL-WITHOUT-MCC

Multiple Level Spinal Fusion Except Cervical without MCC: Inpatient Reimbursement Overview

450-SINGLE-LEVEL-SPINAL-FUSION-EXCEPT-CERVICAL-WITH-MCC-OR-CUSTOM-MADE-ANATOMICALLY-DESIGNED-INTERBODY-FUSION-DEVICE

Single Level Spinal Fusion Except Cervical with MCC or Custom-Made Device: Inpatient Reimbursement Overview

451-SINGLE-LEVEL-SPINAL-FUSION-EXCEPT-CERVICAL-WITHOUT-MCC

Single Level Spinal Fusion Except Cervical without MCC: Inpatient Reimbursement Overview

Showing 1–10 of 104

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

OpenPayer

Tendonitis, Myositis and Bursitis without MCC: Inpatient Reimbursement Overview

Sign up for drg 558 policy alerts

DRG 558 Overview

OpenPayer

Tendonitis, Myositis and Bursitis without MCC: Inpatient Reimbursement Overview

Sign up for drg 558 policy alerts

DRG 558 Overview

Clinical Trials

Related Codes

References

Clinical Trials

Related Codes

References